Glaucoma Trial, Recruiting NCT06523751 Sponsor: Wuerzburg University Hospital Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06523751
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with one of these types of glaucoma: primary open angle glaucoma, pigmentary glaucoma, or pseudoexfoliation glaucoma
  • Your eye pressure is not well controlled even when taking the maximum amount of glaucoma medication you can tolerate
  • Eye scans have shown that the nerve fiber layer at the back of your eye is getting progressively thinner over time
  • Your vision has been getting worse due to increasing blind spots or vision loss related to glaucoma
  • You have a cataract that is affecting your vision AND your doctor has recommended that your eye pressure needs to be lowered or your glaucoma medications reduced

Who may not be able to join:

  • You have been diagnosed with a different type of glaucoma, such as neovascular glaucoma, angle-closure glaucoma, or glaucoma caused by eye inflammation (uveitic glaucoma)
  • You have had previous surgery for glaucoma
  • You have a pre-existing condition that affects the blood pressure around your eye, such as Graves' eye disease, Sturge-Weber syndrome, or certain abnormal connections between arteries and veins in the head (such as a carotid-cavernous fistula) (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Kampik, MD, PhD, Department of Ophthalmology University Hospital Würzburg

Phone: +49 93120120662

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wuerzburg University Hospital
Registry
ClinicalTrials.gov
Start date
13 June 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

IOP; Outflow facility; Surgical success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov